CRL: Charles River Laboratories International, Inc. - Summary | Jitta

Charles River Laboratories International, Inc.

NYSE:CRL

Price
$393.25
Loss Chance
43.1%
6.52JITTA SCORE
74.71%Over Jitta Line
Jitta Ranking
54 / 1,039
914 / 4,577
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (71)
Recent Business Performance (83)
Financial Strength (76)
Return to Shareholders (49)
Competitive Advantage (82)
Jitta Signs
Revenue and EarningConsistent Growth in the past 5 years
Recent Business PerformanceEarning Growth Last Year
Interest Coverage RatioVery Good
SG&A to SalesDecreasing
Key Stats
Jitta Score
Jitta Line
6.52
74.71%
2.26
349.01%
Life Sciences Tools and Services
7.15
146.30%
5.51
11.49%
6.99
131.92%
COMPANY DESCRIPTION
Charles River Laboratories International, Inc., an early-stage contract research company, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment produces and sells research model strains and purpose-bred rats and mice for use by researchers. It also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets and chemical compounds through delivery of non-clinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. It also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free (SPF) fertile chicken eggs, SPF chickens, and diagnostic products used to manufacture vaccines. The company was founded in 1947 and is based in Wilmington, Massachusetts.